Resultats globals: 6 registres trobats en 0.02 segons.
Articles, 6 registres trobats
Articles 6 registres trobats  
1.
15 p, 2.7 MB ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma / Mensali, Nadia (Department of Cellular Therapy. Oslo University Hospital) ; Köksal, Hakan (Department of Cellular Therapy. Oslo University Hospital) ; Joaquina, Sandy (Department of Cellular Therapy. Oslo University Hospital) ; Wernhoff, Patrick (Department of Cellular Therapy. Oslo University Hospital) ; Casey, Nicholas P. (Department of Cellular Therapy. Oslo University Hospital) ; Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Panisello, Carla (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rodríguez, René (Instituto de Salud Carlos III) ; Vimeux, Lene (Université de Paris) ; Juzeniene, Asta (Department of Radiation Biology. Oslo University Hospital) ; Myhre, Marit R. (Department of Cellular Therapy. Oslo University Hospital) ; Fåne, Anne (Department of Cellular Therapy. Oslo University Hospital) ; Castilla Ramírez, Caroline (Virgen del Rocio University Hospital) ; Maggadottir, Solrun Melkork (Department of Cellular Therapy. Oslo University Hospital) ; Duru, Adil Doganay (Nova Southeastern University) ; Georgoudaki, Anna-Maria (Department of Oncology-Pathology. Karolinska Institutet) ; Grad, Iwona (Department of Radiation Biology. Oslo University Hospital) ; Maturana, Andrés Daniel (Nagoya University) ; Gaudernack, Gustav (Department of Cancer Immunology. Oslo University Hospital) ; Kvalheim, Gunnar (Department of Cellular Therapy. Oslo University Hospital) ; Carcaboso, Angel M. (Institut de Recerca Sant Joan de Deu) ; De Álava, Enrique (Department of Normal and Pathological Cytology and Histology. University of Seville) ; Donnadieu, Emma (Université de Paris) ; Bruland, Øyvind S ; Menendez, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Inderberg, Else Marit (Department of Cellular Therapy. Oslo University Hospital) ; Wälchli, Sébastien (Department of Cellular Therapy. Oslo University Hospital)
Osteosarcoma (OS) remains a dismal malignancy in children and young adults, with poor outcome for metastatic and recurrent disease. Immunotherapies in OS are not as promising as in some other cancer types due to intra-tumor heterogeneity and considerable off-target expression of the potentially targetable proteins. [...]
2023 - 10.1038/s41467-023-39097-x
Nature communications, Vol. 14 Núm. 1 (december 2023) , p. 3375  
2.
14 p, 1.7 MB The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia / López-Millán, Belén (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Costales, Paula (EntreChemSL) ; Gutiérrez-Agüera, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Díaz de la Guardia, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Roca Ho, Heleia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Vinyoles, Meritxell (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rubio Gayarre, Alba (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Safi, Rémi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Castaño Cardoso, Julio (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ramírez Orellana, Manuel (Instituto de Investigación Hospital Universitario de la Princesa) ; Anguita, Eduardo (Hospital Clínico San Carlos (Madrid)) ; Jeremias, Irmela (Research Unit Apoptosis in Hematopoietic Stem Cells. Helmholtz Zentrum München) ; Zamora, Lurdes (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rodríguez-Manzaneque, Juan Carlos (GENYO. Centre for Genomics and Oncological Research. Pfizer. Universidad de Granada. Junta de Andalucía) ; Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Morís, Francisco (EntreChemSL) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Patients with AML harboring a constitutively active internal tandem duplication mutation (ITD) in the FMS-like kinase tyrosine kinase (FLT3) receptor generally have a poor prognosis. [...]
2022 - 10.3390/cancers14061593
Cancers, Vol. 14 Núm. 6 (3-2 2022) , p. 1593  
3.
9 p, 21.0 MB Robust in Vitro and in Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell / Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Vinyoles, Meritxell (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; López-Millán, Belén (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Díaz de la Guardia, Rafael (GENYO. Centro Pfizer-Universidad de Granada-Junta de Andalucia de Genomica e Investigacion Oncologica) ; Atucha, Noemí M. (Universidad de Murcia) ; Querol, Sergi (Banc de Sang i Teixits) ; Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Benitez, Raquel (Instituto de Parasitología y Biomedicina "López-Neyra") ; Gonzalez-Rey, Elena (Instituto de Parasitología y Biomedicina "López-Neyra") ; Delgado, Mario (Instituto de Parasitología y Biomedicina "López-Neyra") ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Mesenchymal stromal stem/cells (MSC) therapies are clinically used in a wide range of disorders based on their robust HLA-independent immunosuppressive and anti-inflammatory properties. However, the mechanisms underlying MSC therapeutic activity remain elusive as demonstrated by the unpredictable therapeutic efficacy of MSC infusions reported in multiple clinical trials. [...]
2022 - 10.1093/stcltm/szab007
Stem Cells Translational Medicine, Vol. 11 Núm. 1 (march 2022) , p. 88-96  
4.
13 p, 6.9 MB Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia / Sánchez Martínez, Diego (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Tirado, Nestor (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mensurado, Sofía (Universidade de Lisboa) ; Martínez Moreno, Alba (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gutiérrez-Agüera, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Correia, Daniel V. (Universidade de Lisboa) ; Silva-Santos, Bruno (Universidade de Lisboa) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Background Chimeric antigen receptor (CAR)-T cells have emerged as a breakthrough treatment for relapse/refractory hematological tumors, showing impressive complete remission rates. However, around 50% of the patients relapse before 1-year post-treatment. [...]
2022 - 10.1136/jitc-2022-005400
Journal for immunotherapy of cancer, Vol. 10 Núm. 9 (september 2022) , p. e005400  
5.
13 p, 2.2 MB Enforced sialyl-Lewis-X (sLeX) display in E-selectin ligands by exofucosylation is dispensable for CD19-CAR T-cell activity and bone marrow homing / Sánchez Martínez, Diego (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gutiérrez-Agüera, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Vinyoles, Meritxell (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Palomo, Marta (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Tirado, Néstor (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zanetti, S. R. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Juan, Manel (Hospital Clínic i Provincial de Barcelona) ; Carlet, Michela (Dr von Hauner Children's Hospital, LMU) ; Jeremias, Irmela (Dr von Hauner Children's Hospital, LMU) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
CD19-directed chimeric antigen receptors (CAR) T cells induce impressive rates of complete response in advanced B-cell malignancies, specially in B-cell acute lymphoblastic leukemia (B-ALL). However, CAR T-cell-treated patients eventually progress due to poor CAR T-cell persistence and/or disease relapse. [...]
2021 - 10.1002/ctm2.280
Clinical and Translational Medicine, Vol. 11 (february 2021)  
6.
13 p, 5.4 MB Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity / Zanetti, S. R. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Vinyoles, Meritxell (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Juan, Manel (Hospital Clínic i Provincial de Barcelona) ; Fuster, José Luis (Instituto Murciano de Investigación Biosanitaria) ; Camós, Mireia (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Querol, Sergi (Blood and Tissue Bank) ; Delgado, M. (Instituto de Parasitología y Biomedicina "López-Neyra") ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Background Although adoptive transfer of CD19-directed chimeric antigen receptor (CAR) T-cells (CD19-CAR T-cells) achieves high rates of complete response in patients with B-cell acute lymphoblastic leukemia (B-ALL), relapse is common. [...]
2020 - 10.1136/jitc-2020-001419
Journal for immunotherapy of cancer, Vol. 8 Núm. 2 (31 2020) , p. e001419  

Vegeu també: autors amb noms similars
1 Romecin, P.A.
2 Romecin, Paola
6 Romecin, Paola Alejandra
1 Romecín, P.A.
2 Romecín, Paola
1 Romecín, Paola A.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.